Archive Posts

Update on new cystic fibrosis drug

Wednesday, April 30th, 2014

Ran D Anbar, MDUpstate pulmonologist Ran Anbar, MD, gives us an update on the promising new drug Kalydeco™ that treats the underlying cause of cystic fibrosis, and an ongoing clinical trial at Upstate. Anbar is the director of the pediatric pulmonary and cystic fibrosis center at Upstate Golisano Children’s Hospital, and author of a new book about the impact of psychological factors in the treatment of disease titled “Functional Symptoms in Pediatric Disease: A Clinical Guide.” 


2/19/12 F.D.A. approves new Cystic Fibrosis drug

Friday, February 17th, 2012

Ran D Anbar, MDPulmonologist Ran Anbar talks about cystic fibrosis – what it is and how we have treated it up until now -  and reveals an exiting new drug that treats its underlying cause, rather than just the symptoms.

A Breath of Fresh Air: New Hope for Cystic Fibrosis Treatment [Preview], The Scientific American

The Pediatric Pulmonology Center at Upstate Golisano Children’s Hospital